News & Updates

Show Multimedia Only
Biomarker-driven therapies superior to standard care in breast cancer
Biomarker-driven therapies superior to standard care in breast cancer
02 Nov 2023

Patients with breast cancer may gain greater therapeutic advantages from biomarker-driven than standard-of-care therapies, suggests a study.

Biomarker-driven therapies superior to standard care in breast cancer
02 Nov 2023